ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,033Medicare Part D Prescriptions Filled, Including Refills

Rank: 281 out of 1107

$462K Total Retail Price of All Prescriptions

Rank: 414 out of 1107

350 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 8,581 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 631 368 S3 1 1
LISINOPRIL 469 332 2 2
SIMVASTATIN 312 253 3 5
HYDROCHLOROTHIAZIDE 306 232 4 11
OMEPRAZOLE 287 205 5 4
FUROSEMIDE 248 229 6 7
GABAPENTIN 216 158 7 9
LEVOTHYROXINE SODIUM 200 183 8 3
IBUPROFEN 192 138 9 63
METOPROLOL TARTRATE 185 168 10 10
NEXIUM 181 162 11 18
DONEPEZIL HCL 178 175 12 32
METFORMIN HCL 172 138 13 8
POTASSIUM CHLORIDE 169 159 14 14
WARFARIN SODIUM 166 152 15 15
DICLOFENAC SODIUM 158 121 16 74
CITALOPRAM HBR 154 115 17 17
CARVEDILOL 150 103 18 27
GLIPIZIDE ER 145 123 19 115
AMLODIPINE BESYLATE 131 97 20 6
ROPINIROLE HCL 129 79 21 69
AMITRIPTYLINE HCL 122 90 R 22 48
PREDNISONE 121 101 23 40
SPIRONOLACTONE 116 99 24 72
GLIPIZIDE 112 98 25 64
ATENOLOL 103 74 26 19
SYNTHROID 100 100 27 70
TRAMADOL HCL 98 73 28 26
PRAVASTATIN SODIUM 86 55 29 12
RANITIDINE HCL 85 53 30 21
PROAIR HFA 80 62 31 37
ZOLPIDEM TARTRATE 80 68 31 22
NAMENDA 76 76 33 42
CLONIDINE HCL 70 44 34 53
ATORVASTATIN CALCIUM 69 59 35 13
LOVASTATIN 69 49 35 55
MIRTAZAPINE 69 69 35 61
TRAZODONE HCL 67 43 38 33
COUMADIN 66 66 39 364
BACLOFEN 65 26 40 133
QUINAPRIL HCL 64 51 41 145
AMOX TR-POTASSIUM CLAVULANATE 58 49 42 131
NABUMETONE 58 44 42 181
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 43 44 24
ZETIA 57 54 44 76
PROMETHAZINE HCL 56 40 R 46 44
TAMSULOSIN HCL 54 50 47 30
LANTUS 52 34 48 49
DIVALPROEX SODIUM 52 35 48 96
PLAVIX 51 42 50 39
CEPHALEXIN 50 35 51 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.